9th Annual Update in Liver and Gastrointestinal Diseases

Objectives

At the conclusion of this conference, attendees should be able to:

1. Discuss the current and future therapeutic advances and the role of response-guided therapy in the treatment of Hepatitis C.
2. Describe the New CDC Recommendations for HCV Screening.
3. Implement state-of-the-art advances in the management of viral hepatitis, cirrhosis and screening of hepatocellular carcinoma.
4. Recognize new innovations in endoscopic submucosal dissection.
5. Explain recent therapies for liver cancer including immunotherapy, hormone therapy, chemotherapy and radiation therapy.
6. Identify distinctive and effective clinical management strategies of inflammatory bowel disease.
7. Discuss current and emerging evidence based treatment strategies in liver transplantation.
8. Comprehend new information on the advances in portal hypertension and fatty liver disease.
9. Discuss the new advances in chronic pancreatitis.
10. Describe use of EUS as an interventional tool.